National and Kapodistrian University of Athens
Λειτουργικοί λιποσωμιακοί και δενδριτικοί φορείς βιοφαρμακευτικών ουσιών
Abstract
dc:descriptionThe purpose of this thesis is the development of novel functional liposomal and dendritic drugdelivery systems for efficient insulin encapsulation and their study as potential oral insulindelivery systems.In the first part of this study, unilamellar PEGylated liposomes were prepared which canencapsulate up to 4 mg/mL of insulin. For these systems it is possible to control insulin’srelease rate, at pH 7.4, by varying the number of liposomal surface grafted PEG chains.Moreover, it was shown that degradation of liposomal insulin by proteolytic enzymes issignificantly reduced compared to free insulin.In the second part, the complexation of insulin with a poly(L-lysine) dendrigraft (DL) and aseries of arginine end-functionalized DL or with PEGylated oligolysine and oligoargininehomopeptides at physiological pH was investigated. These positively charged polymersinteract spontaneously with insulin, affording stable ionic complexes, with insulincomplexation efficiencies exceeding 99%. The interaction was studied by dynamic lightscattering, ζ-potential, circular dichroism (CD), and isothermal titration calorimetry. Bindingoccurs in two steps: at low polymer/insulin molar ratios (< 0.1) interaction is accompaniedwith the endothermic dissociation of insulin dimers, while at higher molar ratios complexationof insulin monomers with the polymeric derivatives occurs exothermically. Stabilization ofcomplexed insulin against enzymatic degradation is observed, especially for the highly endfunctionalized arginine dendrigrafts and for the higher molecular weight PEGylatedoligoarginine derivative. Insulin release rates in simulated intestinal fluid can be controlled bythe number of arginine end-groups and by the length of PEG chains. More importantly,released insulin retains its secondary structure as established by CD.In conclusion, complexes of arginine-based peptides with insulin have significant potential as novel insulin delivery systems, given their biodegradable character, the presence of arginineend-groups that are known to enhance insulin intestinal absorption, the ability to controlinsulin release rate and the improved protection of insulin against enzymatic degradation.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sterioti, Nikoletta
- Στεριώτη, Νικολέττα
Subjects
dc:subject × 18- Λιποσώματα
- Ινσουλίνη
- Δενδριτική πολυ(L-λυσίνη)
- Ολιγοπεπτίδια L-λυσίνης
- Ολιγοπεπτίδια αργινίνης
- Πολύ(αιθυλενογλυκόλη)
- Liposomes
- Insulin
- Poly(L-lysine) dendrigrafts
- Lysine-based oligopeptides
- Arginine-based oligopeptides
- Poly(ethylene glycol)
- Φυσικές Επιστήμες
- Χημεία
- Βιολογία
- Natural Sciences
- Chemical Sciences
- Biological Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/44093